Download
Upload.pdf 498,99KB
WeightNameValue
1000 Titel
  • International Society for Extracellular Vesicles and International Society for Cell and Gene Therapy statement on extracellular vesicles from mesenchymal stromal cells and other cells: considerations for potential therapeutic agents to suppress coronavirus disease-19
1000 Autor/in
  1. Börger, Verena |
  2. Weiss, Daniel J. |
  3. Anderson, Johnathon |
  4. BORRAS, FRANCESC E. |
  5. Bussolati, Benedetta |
  6. Carter, David R. F. |
  7. Dominici, Massimo |
  8. Falcón-Pérez, Juan M. |
  9. Gimona, Mario |
  10. Hill, Andrew |
  11. Hoffman, Andrew M. |
  12. de Kleijn, Dominique |
  13. Levine, Bruce |
  14. Lim, Rebecca |
  15. Lötvall, Jan |
  16. Mitsialis, S. Alex |
  17. Monguió-Tortajada, Marta |
  18. MURACA, MAURIZIO |
  19. Nieuwland, Rienk |
  20. Nowocin, Anna |
  21. O'Driscoll, Lorraine |
  22. Ortiz, Luis A. |
  23. Phinney, Donald |
  24. Reischl, Ilona |
  25. Rohde, Eva |
  26. Sanzenbacher, Ralf |
  27. théry, clotilde |
  28. Toh, Wei Seong |
  29. Witwer, Kenneth |
  30. Lim, Sai Kiang |
  31. Giebel, Bernd |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-05-16
1000 Erschienen in
1000 Quellenangabe
  • 22(9):482-485
1000 FRL-Sammlung
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1016/j.jcyt.2020.05.002 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229942/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • The International Society for Cellular and Gene Therapies (ISCT) and the International Society for Extracellular Vesicles (ISEV) recognize the potential of extracellular vesicles (EVs, including exosomes) from mesenchymal stromal cells (MSCs) and possibly other cell sources as treatments for COVID-19. Research and trials in this area are encouraged. However, ISEV and ISCT do not currently endorse the use of EVs or exosomes for any purpose in COVID-19, including but not limited to reducing cytokine storm, exerting regenerative effects or delivering drugs, pending the generation of appropriate manufacturing and quality control provisions, pre-clinical safety and efficacy data, rational clinical trial design and proper regulatory oversight.
1000 Sacherschließung
lokal Gentherapie
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0002-8230-2218|https://frl.publisso.de/adhoc/uri/IFdlaXNzLCBEYW5pZWwgSi4gICA=|https://orcid.org/0000-0001-5404-2298|https://orcid.org/0000-0003-4038-1912|https://orcid.org/0000-0002-3663-5134|https://frl.publisso.de/adhoc/uri/ICBDYXJ0ZXIsIERhdmlkIFIuIEYuICAg|https://orcid.org/0000-0002-4007-1503|https://frl.publisso.de/adhoc/uri/IEZhbGPDs24tUMOpcmV6LCBKdWFuIE0uICA=|https://orcid.org/0000-0002-2242-2015|https://orcid.org/0000-0001-5581-2354|https://frl.publisso.de/adhoc/uri/ICBIb2ZmbWFuLCBBbmRyZXcgTS4gIA==|https://orcid.org/0000-0003-2714-2140|https://orcid.org/0000-0001-6971-8465|https://frl.publisso.de/adhoc/uri/ICBMaW0sIFJlYmVjY2Eg|https://orcid.org/0000-0001-9195-9249|https://orcid.org/0000-0001-8315-7828|https://orcid.org/0000-0003-2125-0810|https://orcid.org/0000-0003-1218-097X|https://orcid.org/0000-0002-5394-2152|https://orcid.org/0000-0001-5612-3286|https://orcid.org/0000-0002-9860-8262|https://frl.publisso.de/adhoc/uri/IE9ydGl6LCBMdWlzIEEuICAgIA==|https://orcid.org/0000-0002-8688-2619|https://frl.publisso.de/adhoc/uri/ICBSZWlzY2hsLCBJbG9uYSAgICA=|https://orcid.org/0000-0001-8692-886X|https://frl.publisso.de/adhoc/uri/ICBTYW56ZW5iYWNoZXIsIFJhbGYgIA==|https://orcid.org/0000-0001-8294-6884|https://orcid.org/0000-0001-9147-6423|https://orcid.org/0000-0003-1664-4233|https://orcid.org/0000-0002-5752-3297|https://orcid.org/0000-0003-2446-948X
1000 Label
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6432387.rdf
1000 Erstellt am 2022-03-21T14:32:53.439+0100
1000 Erstellt von 323
1000 beschreibt frl:6432387
1000 Bearbeitet von 317
1000 Zuletzt bearbeitet 2022-05-05T08:30:10.175+0200
1000 Objekt bearb. Thu May 05 08:30:00 CEST 2022
1000 Vgl. frl:6432387
1000 Oai Id
  1. oai:frl.publisso.de:frl:6432387 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source